However, between 10 and 20 months of age these children develop refractory myoclonic seizures, movement disorders, and/or developmental delays.13 This younger age of onset with KCTD7 mutations (average 16 months) distinguishes these patients from other types of progressive myoclonic epilepsies (PME). The gene discussed is KCTD7; the disease is Progressive myoclonic epilepsy.